The genus *Fonsecaea* comprises etiologic fungal agents of human chromoblastomycosis ([@R1]*--*[@R3]), a chronic cutaneous and subcutaneous infection characterized by slowly expanding nodules that eventually lead to emerging, cauliflower-like, mutilating and disfiguring eruptions. Infection proceeds with muriform cells in tissue provoking a granulomatous immune response. In areas where it is endemic, disease incidence is high. Yegres et al. ([@R4]) and Yëgues-Rodriguez et al. ([@R5]) noted a frequency of 16 cases/1,000 population under arid climatic conditions in rural communities of Venezuela; chromoblastomycosis in that region is caused mainly by *Cladophialophora carrionii*. In contrast, *Fonsecaea* spp. are prevalent in humid tropical climates. Esterre et al. ([@R6]) reported 1,343 cases of chromoblastomycosis from Madagascar, 61.8% of which were caused by *Fonsecaea* spp. Kombila et al. ([@R7]) reported 64 cases in Gabon (equatorial Africa), all caused by *Fonsecaea* spp., and Silva et al. ([@R8]) cited 325 cases in the Amazon region of Brazil, 98% of which had *Fonsecaea* spp. as the etiologic agent. In Sri Lanka, 94% of 71 chromoblastomycosis cases were caused by *Fonsecaea* spp ([@R9]).

*Fonsecaea* contains anamorphic ascomycetes belonging to the family *Herpotrichiellaceae* (order *Chaetothyriales*), which includes black yeasts and relatives ([@R10]*--*[@R12]). The genus comprises 3 sibling species: *F. pedrosoi*, *F. monophora*, and *F. nubica,* each of which has pathogenic potential ([@R10]*,*[@R13]*,*[@R14]). Infection process and routes of dispersal are insufficiently clarified. Humans presumably acquire the infection after being pricked by contaminated thorns or wood splinters, but some agents are substantially more clinically prevalent than their predominantly (hitherto unnamed) environmental counterparts ([@R15]), which indicates that infection is not a random process. In many published case reports, etiologic agents were referred to as *Phialophora pedrosoi* or identified with the obsolete name *F. compacta*, now known to be a mutant *F. pedrosoi* ([@R9]*,*[@R13]*,*[@R16]). Strains are no longer accessible for molecular verification. Hence, no data are available on the epidemiology of the species as defined by sequence data.

Phylogenetically, *Fonsecaea* spp. agents of chromoblastomycosis are flanked by nonpathogenic species ([@R10]) growing on plant debris. Discovery of natural habitat and source of infection by entities emerging on the human host is essential for understanding the evolution of pathogenicity. We present an amplified fragment-length polymorphism (AFLP) DNA fingerprinting study of a worldwide collection of clinical isolates that were identified as *Fonsecaea* spp. by state-of-the-art sequencing methods, supplemented with environmental isolates of the same species. The AFLP technique is a powerful method for discrimination between fungal species and for providing high-resolution fingerprinting data within species ([@R17]*--*[@R19]).

Materials and Methods
=====================

Fungal Strains and Culture Conditions
-------------------------------------

We studied 81 isolates representing the 3 currently recognized *Fonsecaea* spp. Geographic origins and hosts of the strains are listed in the [Table A1](#TA.1){ref-type="table"}; the set include reference strains from the Centraalbureau voor Schimmelcultures (CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands) and fresh isolates from patients and from the environment. Stock cultures were maintained on slants of 2% malt extract agar and oatmeal agar at 24°C.

DNA Extraction and Identification
---------------------------------

Approximately 1 cm^2^ of 14- to 21-day-old cultures were transferred to 2 mL Eppendorf tubes containing 400 µL TEx buffer (Sigma-Aldrich, Zwijndrecht, the Netherlands), pH 9.0 (100 mmol Tris, 40 mmol Na-EDTA) and glass beads (Sigma G9143, Sigma-Aldrich). The fungal material was homogenized with a MoBio vortex (Bohemia, New York, USA) for 1 min. Subsequently, 120 µL of a 10% sodium dodecyl sulfate solution and 10 µL proteinase K (10 mg/mL, Sigma-Aldrich) were added and incubated for 30 min at 55°C; the mixture was vortexed for 3 min. After addition of 120 µL of 5M NaCl and 1/10 vol 10% cetyltrimethylammonium bromide solution (Sigma-Aldrich), the material was incubated for 60 min at 55°C. Then the mixture was vortexed for 3 min. Subsequently, 700 µL SEVAG (24:1, chloroform: isoamyl alcohol) was added, mixed carefully, and centrifuged for 5 min at 4°C at 20,400 × *g*. The supernatant was transferred to a new Eppendorf tube with 225 µL 5M NH~4~ acetate (Sigma-Aldrich), mixed carefully by inverting, incubated for 30 min on ice water, and centrifuged again for 5 min at 4°C at 20,400 × *g*. The supernatant was then transferred to another Eppendorf tube with 0.55 vol isopropanol and centrifuged for 5 min at 20,400 × *g*. Finally, the pellet was washed with 1 mL ice cold 70% ethanol. After drying at room temperature, it was resuspended in 48.5 µL TE buffer (Sigma-Aldrich) (Tris 0.12% wt/vol, Na-EDTA 0.04% wt/vol) and 1.5 µL of RNase (Sigma-Aldrich) and incubated in 37°C for 20--30 min. Quality of genomic DNA was verified on agarose gel. Species were identified on the basis of internal transcribed spacer (ITS), partial cell division cycle (*CDC42*), β-tubulin (*BT2*), and ACT sequences ([@R10]*--*[@R14]).

AFLP Fingerprinting
-------------------

We followed a protocol provided by the manufacturer (Applied Biosystems, Nieuwerkerk aan de IJssel, the Netherlands), with some minor modifications ([@R20]*--*[@R23]). Analyses were performed with 100--200 ng DNA.

Restriction and Ligation of Adaptors
------------------------------------

Two μL of DNA (100 ng/μL) was added to 9 μL restriction and ligation mixture (1.1 μL T4 DNA ligase buffer \[Applied Biosystems\]), 1.1 μL M NaCl, 2 U *Mse*I endonuclease, 10 U *Eco*RI endonuclease (New England Biolabs, Ipswich, UK), 30 U T4 DNA ligase, 1 μL *Mse*I-adaptor, 1 μL *Eco*RI-adaptor, and 3 μL dH~2~0 and incubated at 37°C for 2.5 h. Subsequently, each restriction/ligation reaction was diluted ≈3× by adding 25 μL demineralized water.

Preselective and Selective PCR
------------------------------

In preselective PCR, 2 μL of diluted restriction/ligation product was added to 7.5 μL of AFLP core mix (Applied Biosystems), 0.25 μL of the *Eco*RI core sequence (5′-GAC TGC GTA CCA ATTC-3′), and 0.25 μL of the *Mse*I core sequence (5′-GAT GAG TCC TGA GTAA-3′). The mixture was amplified in an iCycler (Bio-Rad, Hercules, CA, USA) under the following conditions: 2 min at 72°C, followed by 20 cycles of 20 s at 94°C, 30 s at 56°C, and 2 min at 72°C. Each preselective PCR was diluted 2× by adding 10 μL of dH~2~O. In selective PCR, 1.5 μL of diluted preselective PCR products was mixed with 8.5 selective PCR mix containing 0.5 μL *Eco*RI-AC (labeled with FAM \[6-carboxy fluorescein\]), 0.5 μL *Mse*I-A, and 7.5 μL AFLP core mix (Applied Biosystems). The selective PCR conditions were cycling for 2 min at 94°C, followed by 10 cycles of 20 s at 94°C and 30 s at 66°C (decreasing 1°C with each subsequent cycle), and a final extension of 2 min at 72°C. This sequence was followed by 25 cycles of 20 s at 94°C, 30 s at 56°C, and 2 min at 72°C, and a final incubation of 30 min at 60°C.

AFLP Analysis
-------------

FAM-labeled products were prepared for analysis in an ABI PRISM 377 Genetic Analyzer (Applied Biosystems) as follows: the selective PCR products were cleaned with Sephadex G-50, and selective PCR products were mixed with LIZ 500 in the new plate by several times pipetting (first by preparing master mix \[8.7 µL demineralized water plus 0.3 µL Liz 500\], then mixing this with 1.0 µL of selective PCR product by pipetting). The total volume was adjusted to 10 µL with dH~2~O. Denaturation was done at 95°C for 5 min, and then the reaction was snap-cooled on ice water. The LIZ 500 internal size standard in each sample was used for normalization of the fingerprint pattern according to the instruction manual. The densitometric curves were analyzed with BioNumerics software package (version 4.61, Applied Maths, Kortrijk, Belgium), by using the cosine similarity coefficient and the unweighted pair group method with arithmetic means cluster analysis. Statistical reliability of the cluster was investigated by using a cophenetic value, which calculates the correlation between the calculated and the dendrogram-derived similarity. Subdivisions in clusters were checked visually if they were supported by the banding patterns.

Results
=======

Profiles of 81 strains were generated with the *Eco*RI-AC + *Mse*I-A PCR adaptors. Fingerprints contained ≈60--70 bands in a 50--500-bp range. Another selective PCR with *Eco*RI core sequence+C and *Mse*I core sequence+A primer combination used elsewhere in related fungi ([@R24]) resulted in nonscorable fingerprints because of amplification of too many or only faint bands. Dendrograms derived from the AFLP banding patterns of *Fonsecaea* spp. were generated by using the unweighted pair group method with arithmetic means cluster analysis ([Figure A1](#FA.1){ref-type="fig"}). At [\>]{.ul}62.50% similarity, 3 main clusters were found that matched with existing species on the basis of multilocus sequence analysis (ITS, *CDC42*, *BT2,* and *ACT1*), i.e., *F. pedrosoi*, *F. monophora*, and *F. nubica*. At an automatic cutoff value option set at \<62.5% similarity, the *F. monophora* and *F. nubica* clusters were subdivided in 2 evident groups each, leading to a total of 5 clusters (1--5) interpreted as populations. Clusters 1 and 2 matched with *F. nubica*, clusters 3 and 4 with *F. monophora*, and cluster 5 with *F. pedrosoi*. Individual bands varied within the profiles, but further subclustering was limited, e.g., in a slightly deviating derived subclade in population 5. The groups defined above by AFLP analysis are interpreted as populations (1--5) in the text below. In population 5, some strains were nearly 100% identical, e.g., CBS 122341, 122343, 122345, and 122349, all originating from patients with chromoblastomycosis in Mexico City, Mexico ([Figure A1](#FA.1){ref-type="fig"}; [Table A1](#TA.1){ref-type="table"}).

We determined the geographic distributions of the 5 main populations of *Fonsecaea* strains ([Figure](#Fa){ref-type="fig"}). Areas endemic for *Fonsecaea*, judging from the literature, are in tropical and subtropical climate zones. Population 1 comprised a cluster of *F. nubica* strains originating from humans with chromoblastomycosis in Guangdong, People's Republic of China. Population 2 of the same species comprised 4 strains, 2 of which originated from humans with chromoblastomycosis in South America, 1 from France, and 1 with unknown origin. The profiles were too different to trace to any clonal identity. Population 3 (*F. monophora*) comprised 15 strains, most of which were isolated from humans with chromoblastomycosis in South America; 1 originated from the United States, and 1 originated from Haikou in southern China. Two strains were isolated from decaying plants in Brazil, and the second US strain was derived from a human with a brain infection. Two other strains from human brain infections in Brazil and in Africa had unique profiles that could not be unambiguously linked to any other isolate. Another African strain, from a patient with chromoblastomycosis who lived in Spain and had acquired the infection 36 years earlier in Guinea ([@R25]), also had a unique profile. Population 4 of *F. monophora* comprised 16 strains from Guangdong in southern China, and 1 came from Shandong, ≈1,850 km distant. All had derived from humans with chromoblastomycosis. A single sample originated from a patient with a brain infection who lived in the United Kingdom ([@R26]); whether the patient had visited southern China could not be established. In population 5 (*F. pedrosoi*), most strains originated from chromoblastomycosis patients in Central and South America. Some geographic clustering was visible, i.e., the derived group of strains from South America (uppermost clade of population 5 in the [Figure A1](#FA.1){ref-type="fig"}) was segregated from those from Central America. Several of the strains from South American originated from soil and were isolated through mouse passage. One strain from an ear of a gazelle in Libya and 1 from a human with chromoblastomycosis in the Netherlands could not directly be linked to any other strain.

Discussion
==========

AFLP typing is comparable to use of other DNA markers, such as random amplified polymorphic DNA, restriction fragment-length polymorphism, or microsatellites, in terms of time and cost efficiency, reproducibility, and resolution ([@R27]). The technique has emerged as a major epidemiologic tool with broad application in ecology, population genetics, pathotyping, DNA fingerprinting, and quantitative trait loci mapping ([@R28]). AFLP fingerprinting is useful for the molecular characterization of microorganisms with relatively large genomes, including various fungal species ([@R18]*,*[@R19]*,*[@R21]*--*[@R23]*,*[@R29]*,*[@R30]). In a preliminary experiment that used different primer combinations, the combination *Eco*RI-AC + *Mse*I-A adaptors gave excellent results, yielding readable profiles with well-separated bands.

The degree of variation in *Fonsecaea* appeared to differ between species. The major 5 clusters were separated at \<62.5% similarity, with significant differences in the presence of major fragments, several of which were unique to individual isolates or subpopulations. Populations 1 and 2, 3 and 4, and 5 corresponded with species borderlines established recently by Najafzadeh et al. ([@R10]*,*[@R14]) on the basis of multilocus sequencing with ITS, *CDC42*, *BT2*, and *ACT1*. Population 5 (*F. pedrosoi*) varied least at \>71.7% similarity, with limited reproducible substructure being discernable. Nearly all isolates of this species originated from South and Central America (Venezuela, Brazil, Mexico, Argentina, Puerto Rico, and Uruguay). One isolate from a human with chromoblastomycosis in the Netherlands was likely to have been imported ([@R13]). One isolate from a gazelle ear in Libya, northern Africa, was the only geographic exception that could not be explained. Clusters of strains that could be grouped as being visually identical and with similarities \>71.7% ([Figure A1](#FA.1){ref-type="fig"}; [Table A1](#TA.1){ref-type="table"}) were mostly collected at close geographic distance from each other. This finding suggests that vectors of dispersal for *Fonsecaea* spp. are slow, leading to detectable regional diversification. The relatively low degree of variation of *F. pedrosoi* and confinement to Central and South America indicate a founder effect, the species being the most recently emerged taxon in *Fonsecaea*. *F. monophora* and *F. nubica* were distributed worldwide but were geographically diverse in that population 4 of *F. monophora* was nearly confined to China, with highly similar profiles ([Figure A1](#FA.1){ref-type="fig"}). One strain of this population 4, CBS 117238, originated from a brain infection in a human in the United Kingdom; whether this patient had emigrated from China could not be determined from the original publication ([@R25]). *F. monophora* population 3 was found mainly in the Western Hemisphere, particularly in Brazil. Judging from the near identity of profiles of strains isolated in 1937 (CBS 271.37) and in 1999 (CBS 102245) ([Figure A1](#FA.1){ref-type="fig"}), we can conclude that clones are maintained locally over decades. The 2 US strains presumably derived from immigrants from South America or Central America. Population 3 was also found in Africa and in Haikou in China, 600 km from Guangdong, where population 4 of *F. monophora* is prevalent. Strains of *F. nubica* show a similar bipartition over Asia and the Western Hemisphere, with a prevalently Chinese (population 1) and a prevalently Brazilian (population 2) population, and a presumed infected immigrant in France. Kawasaki et al. ([@R31]*,*[@R32]) provided similar data on the basis of restriction fragment-length polymorphism of mitochondrial DNA, showing that *Fonsecaea* spp. from Japan and China differed consistently from isolates from Central and South America.

Nearly all *Fonsecaea* spp. isolates available in culture collections originate from mammals, mostly humans with chromoblastomycosis, and were rarely recovered from the environment of symptomatic patients despite several attempts ([@R33]). Occasionally, *F. pedrosoi* was isolated from mice that were euthanized for isolation of black yeasts after they had been inoculated with environmental samples ([@R34]). This information suggests that *Fonsecaea* spp., particularly *F. pedrosoi*, have a competitive advantage by using this enrichment source. Mouse passage proved to be more efficient for environmental isolation of etiologic agents of chromoblastomycosis than general methods such as oil flotation ([@R35]). The latter technique mostly isolates other environmental *Fonsecaea* spp. that are not known to be pathogenic to humans ([@R33]).

In humans with chromoblastomycosis, the male:female ratio of patients is 63:2. This male preponderance of 97% cannot be explained by different exposition rates. Distinct male preponderance is also noted in the neurotropic relative, *Cladophialophora bantiana* (G.S. de Hoog, unpub. data). Population 3 of *F. monophora* has a wider clinical spectrum than the remaining groups, comprising, in addition to chromoblastomycosis, several isolates from human brain infection. This population also comprised some isolates from soil and plant debris acquired without use of mammal baits. Coexistence of closely interrelated entities differing in pathogenicity and virulence seems likely in *Fonsecaea* spp., as was also suggested for black yeasts (A.H.G. Gerrits van den Ende et al., unpub. data).

Our data demonstrate that AFLP fingerprinting is a tool that produces highly reproducible results for molecular epidemiology. The use of AFLP showed that local *Fonsecaea* agents of chromoblastomycosis seem able to be maintained over 70 years, and therefore epidemiologic profiles take the structure of expanding clones. By locality, patients are infected by only a limited number of genotypes. The fungi disperse slowly, leading to appreciable geographic structuring, which ultimately may lead to allopatric speciation (diversification resulting from geographic barriers). Few environmental strains have been recovered during repeated isolation experiments, whereas *Fonsecaea* spp. accumulates substantially in the human host. The mechanisms behind their pathology remain unexplained.

*Suggested citation for this article:* Najafzadeh MJ, Sun J, Vicente VA, Klaassen CHW, Bonifaz A, Gerrits van den Ende AHG, et al. Molecular epidemiology of *Fonsecaea* species. Emerg Infect Dis \[serial on the Internet\]. 2011 Mar \[*date cited*\]. <http://dx.doi.org/10.3201/1703.100555>
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###### *Fonsecaea* spp. isolates used for amplified fragment-length polymorphism analyses

  Taxonomic name   CBS number   Other reference(s)                 Origin                     Host/sex   Location                              Population
  ---------------- ------------ ---------------------------------- -------------------------- ---------- ------------------------------------- ------------
  *F. nubica*      CBS 121733   dH 18411, SUMS 0011                Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 125199   dH 20427                           Chromoblastomycosis        Human/F    China, Guangdong                      1
                   CBS 125186   dH 20429                           Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 125200   dH 20425                           Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 121720   dH 18398, SUMS 0251                Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 125198   dH 20418                           Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 121734   dH 18412, SUMS 0255                Chromoblastomycosis        Human/M    China, Guangdong                      1
                   CBS 271.33   dH 15659, ATCC 18658, IMI 134458   Chromoblastomycosis        Human/M    South America                         2
                   CBS 557.76   ATCC 28174                         Unknown                    Unknown    Unknown                               2
                   CBS 270.37   dH 15657                           Unknown                    Unknown    France                                2
                   CBS 277.29   dH 15668                           Chromoblastomycosis        Human/M    Brazil                                2
  *F. monophora*   CBS 102243   dH 11607                           Chromoblastomycosis        Human/M    Brazil, Parana, Ibituva               3
                   CBS 117236   dH 15330, UTHSC 04-2904            Brain                      Human/M    United States                         3
                   CBS 102246   dH 11611                           Chromoblastomycosis        Human/M    Brazil, Parana, Campo Largo           3
                   CBS 102242   dH 11606                           Chromoblastomycosis        Human/M    Brazil, Santa Catarina, Curitibanos   3
                   CSB 102225   dH 11585                           Decaying wood              Plant      Brazil, Parana, Colombo               3
                   CSB 269.37   dH 12659                           Chromoblastomycosis        Human      South America                         3
                   CSB 102238   dH 11602                           Soil                       Soil       Brazil, Parana, Tibagi River          3
                   CBS 117237   dH 15331, UTHSC 04-2631            Chromoblastomycosis        Human/M    United States                         3
                   CBS 102229   dH 11590                           Decaying vegetable cover   Plant      Brazil, Parana, Piraquara             3
                   CBS 397.48   dH 15828, ATCC 9475                Chromoblastomycosis        Human/M    South America                         3
                   CBS 115830   dH 12978                           Brain                      Human/M    Brazil                                3
                   CBS125189    dH 20421                           Chromoblastomycosis        Human/M    China, Haikou                         3
                   CBS 100430   ATCC 32280                         Brain                      Human/M    Africa                                3
                   CBS 123849   dH 20215                           Chromoblastomycosis        Human/F    Africa, Guinea                        3
                   CBS 102248   dH 11613                           Chromoblastomycosis        Human/M    Brazil, Parana, Piraquara             3
                   CBS 121725   dH 18403, SUMS 0250                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121728   dH 18406, SUMS 0158                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121726   dH 18404, SUMS 0192                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121727   dH 18405, SUMS 0190                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121721   dH 18399, SUMS 0246                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125193   dH 20426                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125195   dH 20417                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125196   dH 20419                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125197   dH 20420                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121732   dH 18410, SUMS 0012                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125190   dH 20422                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 125192   dH 20424                           Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 117238   dH 13130, UTHSC R-3486             Brain                      Human      United Kingdom, England               4
                   CBS 121731   dH 18409, SUMS 0013                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121730   dH 18408, SUMS 0014                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 121722   dH 18400, SUMS 0247                Chromoblastomycosis        Human/M    China, Guangdong                      4
                   CBS 122742   dH 19251, SUMS 0147                Chromoblastomycosis        Human      China, Shandong                       4
                   CBS 121724   dH 18402, SUMS 0200                Chromoblastomycosis        Human/M    China, Guangdong                      4
  *F. pedrosoi*    CBS 273.66   dH 15663                           Mouse passage              Soil       Venezuela                             5
                   CBS 271.37   dH 15659, ATCC 18658, IMI 134458   Chromoblastomycosis        Human/M    South America                         5
                   CBS 671.66   dH 16159                           Mouse passage              Soil       Venezuela                             5
                   CBS 274.66   dH 15665                           Mouse passage              Soil       Venezuela                             5
                   CBS 102245   dH 11610                           Chromoblastomycosis        Human/M    Brazil, Parana, Ampere                5
                   CBS 659.76   dH 16142, ATCC 28303               Chromoblastomycosis        Human/M    Argentina                             5
                   CBS 102247   dH 11612                           Chromoblastomycosis        Human/M    Brazil, Parana                        5
                   CBS 122740   dH 18430, Bonifaz 002200           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CBS 122737   dH 18896                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5a
                   CBS 122735   dH 18898                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5a
                   CBS 122736   dH 18897                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5a
                   CBS 122739   dH 18894                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5a
                   CBS 122732   dH 18901                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CSB 122733   dH 18900                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CBS 122849   dH 18902                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5b
                   CBS 122738   dH 18895                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5b
                   CBS 122731   dH 18903                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5b
                   CBS 122734   dH 18899                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5b
                   CBS 102244   dH 11608                           Chromoblastomycosis        Human/M    Brazil, Parana, Ipora                 5
                   CBS 122729   dH 18905                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CBS 122730   dH 18904                           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CBS 285.47   dH 15680, ATCC 10222               Chromoblastomycosis        Human/M    Puerto Rico                           5
                   CBS 342.34   dH 15773                           Chromoblastomycosis        Human/M    Puerto Rico                           5
                   CBS 670.66   dH 16157                           Mouse passage              Soil       Venezuela                             5
                   CBS 122741   dH 18431, Bonifaz 02300            Chromoblastomycosis        Human/M    Mexico, Mexico City                   5
                   CBS 122729   dH 18905                           Chromoblastomycosis        Human      Mexico, Mexico City                   5
                   CBS 212.77   dH 15549                           Chromoblastomycosis        Human/M    Netherlands, Amsterdam                5
                   CBS 117910   dH 14477                           Chromoblastomycosis        Human/M    Venezuela, Coro, Falcón State         5
                   CBS 272.37   dH 15661                           Chromoblastomycosis        Human      Brazil                                5
                   CBS 122345   dH 18914, Bonifaz 121-06           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 122343   dH 18916, Bonifaz 122-07           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 122341   dH 18918, Bonifaz 345-07           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 122349   dH 18910, Bonifaz 234-04           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 122347   dH 18912, Bonifaz 0257-05          Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 122346   dH 18913, Bonifaz 333-05           Chromoblastomycosis        Human/M    Mexico, Mexico City                   5c
                   CBS 253.49   dH 15620                           Chromoblastomycosis        Human      Uruguay, Montevideo                   5
                   CBS 201.31   dH 15523                           Gazelle, ear               Animal     Libya, Cyrenaica, Derna               5

\*ATCC, American Type Culture Collection, Manassas, VA, USA; CBS, Centraalbureau voor Schimmelcultures, Utrecht, the Netherlands; dH, G.S. de Hoog working collection; SUMS, Sun Yat-Sen University Medical Science, Guangzhou, People's Republic of China; IMI, International Mycological Institute, London, UK; UTHSC, Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

![Geographic distribution of *Fonsecaea* spp. samples analyzed by using amplified fragment-length polymorphism. Light pink shading indicates zone of clinical *Fonsecaea* spp. endemicity, according to published case reports. Sizes of pies and numbers reported within the pies denote the number of strains examined; colors represent *Fonsecaea* spp. populations: orange, *F. nubica* population 1; fuchsia, *F. nubica* population 2; dark blue, *F. monophora* population 3; light blue, *F. monophora* population 4; yellow, *F. pedrosoi* population 5.](10-0555-F){#Fa}

![Clustering of amplified fragment-length polymorphism banding pattern of isolates of *Fonsecaea* spp. analyzed by using unweighted pair group method with arithmetic means. Red bars indicate clonal dispersal. Clusters 1 and 2 are *F. nubica*, clusters 3 and 4 are *F. monophora*, and cluster 5 is *F. pedrosoi*.](10-0555-appF){#FA.1}
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